Insider trades
Bios Equity COF, Director of Actuate Therapeutics ACTU, has filed 3 purchases and 6 sales on the open market. The latest trade was on 25/06/27.
Bios Equity COF
Director
- Company
- Actuate Therapeutics ACTU
- First filing
- 24/08/20
- Trades
- 68 trades
- Buys / sales
- 3 / 6
- 12-month net buying
- No record
- Last trade
- 25/06/27
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market buy | 25/06/27 | 25/06/30 | 71,428 sh | $7.00 | $499,996 | +57.1% | |
ACTU | Open-market saleAmendment | 24/08/14 | 24/08/20 | 24,999 sh3 trades | $8.00avg. | $199,992 | −16.0% |
ACTU | Open-market buy | 24/08/14 | 24/08/14 | 500,000 sh2 trades | $8.00avg. | $4,000,000 | No record |
ACTU | Open-market sale | 24/08/14 | 24/08/14 | 24,999 sh3 trades | $9.00avg. | $224,991 | −16.0% |